On Friday, Clover Health Investments Corp (NASDAQ: CLOV) opened lower -5.88% from the last session, before settling in for the closing price of $0.71. Price fluctuations for CLOV have ranged from $0.71 to $1.63 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 52.25% over the past five years. Company’s average yearly earnings per share was noted 50.14% at the time writing. With a float of $375.65 million, this company’s outstanding shares have now reached $393.27 million.
Let’s look at the performance matrix of the company that is accounted for 552 employees.
Clover Health Investments Corp (CLOV) Insider Updates
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Clover Health Investments Corp is 23.88%, while institutional ownership is 19.65%. The most recent insider transaction that took place on Mar 14 ’24, was worth 100,010. In this transaction Director of this company bought 137,000 shares at a rate of $0.73, taking the stock ownership to the 538,841 shares. Before that another transaction happened on Mar 14 ’24, when Company’s Director bought 13,625 for $0.73, making the entire transaction worth $9,946. This insider now owns 15,125 shares in total.
Clover Health Investments Corp (CLOV) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 19.10% during the next five years compared to -585.84% drop over the previous five years of trading.
Clover Health Investments Corp (NASDAQ: CLOV) Trading Performance Indicators
Check out the current performance indicators for Clover Health Investments Corp (CLOV). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.16.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.44, a number that is poised to hit -0.07 in the next quarter and is forecasted to reach -0.20 in one year’s time.
Technical Analysis of Clover Health Investments Corp (CLOV)
Clover Health Investments Corp (NASDAQ: CLOV) saw its 5-day average volume 7.41 million, a negative change from its year-to-date volume of 9.26 million. As of the previous 9 days, the stock’s Stochastic %D was 9.15%. Additionally, its Average True Range was 0.04.
During the past 100 days, Clover Health Investments Corp’s (CLOV) raw stochastic average was set at 2.44%, which indicates a significant decrease from 5.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 37.67% in the past 14 days, which was lower than the 54.35% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8510, while its 200-day Moving Average is $1.0114. Nevertheless, the first resistance level for the watch stands at $0.7066 in the near term. At $0.7432, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7664. If the price goes on to break the first support level at $0.6468, it is likely to go to the next support level at $0.6236. Assuming the price breaks the second support level, the third support level stands at $0.5870.
Clover Health Investments Corp (NASDAQ: CLOV) Key Stats
There are currently 495,292K shares outstanding in the company with a market cap of 330.70 million. Presently, the company’s annual sales total 2,034 M according to its annual income of -213,360 K. Last quarter, the company’s sales amounted to 510,250 K and its income totaled -70,470 K.
